<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2025-22-3-06</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2901</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Особенности продукции ИЛ-8 и ИЛ-10 у беременных с урогенитальными инфекциями</article-title><trans-title-group xml:lang="en"><trans-title>Features of IL-8 and IL-10 production in pregnant women with urogenital infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0718-8881</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захаренкова</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharenkova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захаренкова Татьяна Николаевна - к.м.н., доцент, заведующий кафедрой акушерства и гинекологии с курсом.</p><p>Гомель</p></bio><bio xml:lang="en"><p>Tatsiana N. Zakharenkova - Candidate of Medical Sciences, Associate Professor, Head of the Department of Obstetrics and Gynecology with the course of Advanced Training and Retraining.</p><p>Gomel</p></bio><email xlink:type="simple">tera03@yandex.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0798-9616</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Приходько</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Prikhodko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Приходько Анастасия Николаевна - ассистент кафедры акушерства и гинекологии с курсом ФПКиП.</p><p>Гомель</p></bio><bio xml:lang="en"><p>Anastasia N. Prikhodko - Assistant at the Department of Obstetrics and Gynecology with the course of Advanced Training and Retraining.</p><p>Gomel</p></bio><email xlink:type="simple">nastya.prikhodko2019@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2025</year></pub-date><volume>22</volume><issue>3</issue><fpage>51</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Захаренкова Т.Н., Приходько А.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Захаренкова Т.Н., Приходько А.Н.</copyright-holder><copyright-holder xml:lang="en">Zakharenkova T.N., Prikhodko A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2901">https://journal.gsmu.by/jour/article/view/2901</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Определить особенности продукции интерлейкина 8 (ИЛ-8) и интерлейкина 10 (ИЛ-10) у беременных с урогенитальными инфекциями (УГИ) в первом триместре, их роль для прогноза акушерских и перинатальных осложнений.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В проспективное когортное исследование включено 98 беременных в первом триместре, из которых у 66 диагностированы генитальные инфекции (ГИ) — основная группа, у 8 пациенток ГИ сочетались с инфекцией мочевыводящих путей (ИМП) — группа сравнения, 24 беременные без УГИ составили контрольную группу. Концентрацию ИЛ-8 и ИЛ-10 в сыворотке крови определяли методом иммуноферментного анализа (ИФА). Оценивали особенности течения беременности, родов, состояние новорожденных.</p></sec><sec><title>Результаты</title><p>Результаты. Системная продукция ИЛ-8 и ИЛ-10 в первом триместре беременности не зависит от наличия ГИ. Рецидиву у пациенток основной группы предшествовали более высокие сывороточные уровни ИЛ-8, определенные у беременных в первом триместре с диагностированной ГИ (p = 0,0001; Z = 3,794). При концентрации ИЛ-8 более 7,6 пг/мл у беременных с ГИ в первом триместре с чувствительностью 82,4 % и специфичностью 83,7 % можно прогнозировать развитие рецидива ГИ во втором–третьем триместре (AUC = 0,809; 95 % СI 0,694-0,895; р = 0,0001).</p><p>Формированию плацентарной недостаточности (ПН) у пациенток основной и контрольной групп предшествовали более высокие концентрации ИЛ-8 в первом триместре беременности (pо = 0,0001; Z = 3,871; pк = 0,025; Z = 2,235). У беременных без УГИ при сывороточном уровне ИЛ-8 более 14,15 пг/мл можно прогнозировать развитие ПН с чувствительностью 100 % и специфичностью 95,5 % (AUC = 0,977; 95 % СI 0,817-0,988; р = 0,0001).</p><p>В основной и контрольной группах развитие угрозы прерывания беременности (УПБ) ассоциировано с более высокими сывороточными уровнями ИЛ-10 в первом триместре беременности (pо = 0,007; Z = 2,682; pк = 0,031; Z = 2,153).</p></sec><sec><title>Заключение</title><p>Заключение. Определение уровней ИЛ-8 и ИЛ-10 в сыворотке крови женщин в первом триместре беременности позволяет прогнозировать развитие таких гестационных осложнений, как УПБ, развитие ГИ и ПН, своевременно формировать группы риска для проведения медицинской профилактики этих осложнений и тем самым улучшить материнские и перинатальные исходы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To determine features of IL-8 and IL-10 production in pregnant women with urogenital infections (UGI) in the first trimester, and their role for prognosis of obstetric and perinatal complications.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The prospective cohort study included 98 pregnant women in the first trimester, of which 66 patients were diagnosed with genital infections (GI) — main group, 8 had genital infections combined with urinary tract infection — comparison group, and 24 pregnant women without urogenital infection formed the control group. Concentration of IL-8 and IL-10 in the blood serum was determined by the enzyme immunoassay method. The characteristics of the course of pregnancy, childbirth, and the condition of the newborns were assessed.</p></sec><sec><title>Results</title><p>Results. Systemic production of IL-8 and IL-10 in the first trimester of pregnancy does not depend on the presence of genital infection. Recurrence in patients of the main group is preceded by higher serum levels of IL-8, determined in pregnant women in the first trimester with diagnosed GI (p=0.0001; Z=3.794). It is possible to predict the development of a relapse of GI in the second-third trimester (AUC=0.809; 95 % CI 0.694-0.895; p=0.0001) at IL-8 concentration of more than 7.6 pg/ml in pregnant women with GI in the first trimester with a sensitivity of 82.4% and a specificity of 83.7%.</p><p>The formation of placental insufficiency in patients of the main and control groups was preceded by higher concentrations of IL-8 in the first trimester of pregnancy (pо = 0.0001; Z=3.871; pк =0.025; Z=2.235). In pregnant women without UGI with a serum IL-8 level of more than 14.15 pg/ml, it is possible to predict the development of placental insufficiency with a sensitivity of 100% and a specificity of 95.5% (AUC=0.977; 95% CI 0.817-0.988; p=0.0001).</p><p>Development of threatened miscarriage was associated with higher serum levels of IL-10 in the first trimester of pregnancy (pо=0.007; Z=2.682; pк =0.031; Z= 2.153) in the main and control groups.</p></sec><sec><title>Conclusion</title><p>Conclusion. Determination of IL-8 and IL-10 levels in the blood serum of women in the first trimester of pregnancy allows predicting the development of gestational complications such as threatened miscarriage, development of genital infection and placental insufficiency, development of genital infection and placental insufficiency, timely formation of risk groups for medical prevention of these complications and, thereby, improvement of maternal and perinatal outcomes.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>цитокины</kwd><kwd>урогенитальные инфекции</kwd><kwd>внутриутробная инфекция</kwd><kwd>плацентарная недостаточность</kwd><kwd>угроза прерывания беременности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>interleukins</kwd><kwd>urogenital infections</kwd><kwd>intrauterine infection</kwd><kwd>pregnancy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено без спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study was conducted without sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tian M, Li Q, Zheng T, Yang S, Chen F, Guan W, Zhang S. Maternal microbe-specific modulation of the offspring microbiome and development during pregnancy and lactation. Gut Microbes. 2023;15(1): 22-26. DOI: https://doi.org/10.1080/19490976.2023.2206505</mixed-citation><mixed-citation xml:lang="en">Tian M, Li Q, Zheng T, Yang S, Chen F, Guan W, Zhang S. Maternal microbe-specific modulation of the offspring microbiome and development during pregnancy and lactation. Gut Microbes. 2023;15(1): 22-26. DOI: https://doi.org/10.1080/19490976.2023.2206505</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Y, Tang L, Hu M, Xiang ZY, Hu Y, Liu Q. Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals. Clin. Chim. Acta. 2020;50(2):116-119. DOI: https://doi.org/10.1016/j.cca.2019.12.013</mixed-citation><mixed-citation xml:lang="en">Fu Y, Tang L, Hu M, Xiang ZY, Hu Y, Liu Q. Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals. Clin. Chim. Acta. 2020;50(2):116-119. DOI: https://doi.org/10.1016/j.cca.2019.12.013</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Spence T, Allsopp PJ, Yeates AJ, Mulhern MS, Strain JJ, McSorley EM. Maternal serum cytokine concentrations in healthy pregnancy and preeclampsia. Journal of pregnancy. 2021; 2021(1): 2-26. DOI: https://doi.org/10.1155/2021/6649608//2021:6649608</mixed-citation><mixed-citation xml:lang="en">Spence T, Allsopp PJ, Yeates AJ, Mulhern MS, Strain JJ, McSorley EM. Maternal serum cytokine concentrations in healthy pregnancy and preeclampsia. Journal of pregnancy. 2021; 2021(1): 2-26. DOI: https://doi.org/10.1155/2021/6649608//2021:6649608</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cakir SC, Dorum BA, Koksal N, Ozkan H. The effects of maternal preeclampsia on inflammatory cytokines and clinical outcomes in premature infants. Pakistan Journal of Medical Sciences. 2020;36(2):26-31. DOI: https://doi.org/10.12669/pjms.36.2.1316</mixed-citation><mixed-citation xml:lang="en">Cakir SC, Dorum BA, Koksal N, Ozkan H. The effects of maternal preeclampsia on inflammatory cytokines and clinical outcomes in premature infants. Pakistan Journal of Medical Sciences. 2020;36(2):26-31. DOI: https://doi.org/10.12669/pjms.36.2.1316</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cobo T, Aldecoa V, Figueras F, Herranz A, Ferrero S, Izquierdo M, et al. Development and validation of a multivariate model for predicting spontaneous preterm birth and amniotic microbial invasion in women with preterm labor. ObstetGynecol. 2020; 223(3):421. DOI: http://dx.doi.org/10.1016/j.ajog.2020.02.049</mixed-citation><mixed-citation xml:lang="en">Cobo T, Aldecoa V, Figueras F, Herranz A, Ferrero S, Izquierdo M, et al. Development and validation of a multivariate model for predicting spontaneous preterm birth and amniotic microbial invasion in women with preterm labor. ObstetGynecol. 2020; 223(3):421. DOI: http://dx.doi.org/10.1016/j.ajog.2020.02.049</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tapilskaya NI, Savicheva AM, Shalepo KV, Budilovskaya OV, Gzgzyan AM, Bespalova ON, et al. Local Immune Biomarker Expression Depending on the Uterine Microbiota in Patients with Idiopathic Infertility. Int J Mol Sci. 2023; 24(8):757. DOI: http://dx.doi.org/10.3390/ijms24087572</mixed-citation><mixed-citation xml:lang="en">Tapilskaya NI, Savicheva AM, Shalepo KV, Budilovskaya OV, Gzgzyan AM, Bespalova ON, et al. Local Immune Biomarker Expression Depending on the Uterine Microbiota in Patients with Idiopathic Infertility. Int J Mol Sci. 2023; 24(8):757. DOI: http://dx.doi.org/10.3390/ijms24087572</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cappelletti M, Presicce P, Kallapur SG. Immunobiology of acute chorioamnionitis. Front Immunol. 2020;11:649. DOI: http://dx.doi.org/10.3389/fimmu.2020.00649</mixed-citation><mixed-citation xml:lang="en">Cappelletti M, Presicce P, Kallapur SG. Immunobiology of acute chorioamnionitis. Front Immunol. 2020;11:649. DOI: http://dx.doi.org/10.3389/fimmu.2020.00649</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson LS, Stelzer IA, Tsai AS, Ghaemi MS, Han X, et al. Multiomic immune clockworks of pregnancy. Semin. Immunopathol. 2020;42: 397-412. DOI: https://doi.org/10.1007/s00281-019-00772-1</mixed-citation><mixed-citation xml:lang="en">Peterson LS, Stelzer IA, Tsai AS, Ghaemi MS, Han X, et al. Multiomic immune clockworks of pregnancy. Semin. Immunopathol. 2020;42: 397-412. DOI: https://doi.org/10.1007/s00281-019-00772-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jeong S, Cho WК, Jo Y. Effects of immune checkpoint proteins, cytokines and microbiome on patients with cervical insufficiency and preterm labor. Front. Immunol 2023;14:1-10. DOI: https://doi.org/10.3389/fimmu.2023.1228647</mixed-citation><mixed-citation xml:lang="en">Jeong S, Cho WК, Jo Y. Effects of immune checkpoint proteins, cytokines and microbiome on patients with cervical insufficiency and preterm labor. Front. Immunol 2023;14:1-10. DOI: https://doi.org/10.3389/fimmu.2023.1228647</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Дубарева Ю.А., Сероштанова Д.Н. Роль эндотелиальной дисфункции и субклинического воспаления в развитии акушерских и перинатальных осложнений у пациенток с сахарным диабетом. Acta Biomedica Scientifica. 2021; 6(3):9-16. DOI: http://dx.doi.org/10.29413/ABS.2021-6.3.1</mixed-citation><mixed-citation xml:lang="en">Dudareva JA, Seroshtanova DN. The role of endothelial dysfunction and subclinical inflammation in the development of obstetric and perinatal complications in diabetes mellitus patients. Acta Biomedica Scientifica (East siberian biomedical journal). 2021;6(3):9-16. (In Russ.). DOI: http://dx.doi.org/10.29413/ABS.2021-6.3.1</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baud A, Hillion KH, Plainvert C, Tessier V, Tazi A, Mandelbrot L, et al. Microbial diversity in the vaginal microbiota and its link to pregnancy outcomes. Scientific Reports. 2023; 13(1):9061. DOI: http://dx.doi.org/10.1038/s41598-023-39583-8</mixed-citation><mixed-citation xml:lang="en">Baud A, Hillion KH, Plainvert C, Tessier V, Tazi A, Mandelbrot L, et al. Microbial diversity in the vaginal microbiota and its link to pregnancy outcomes. Scientific Reports. 2023; 13(1):9061. DOI: http://dx.doi.org/10.1038/s41598-023-39583-8</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Солеева Н., Гулшайдо М., Насимова Н. Плацентарная недостаточность: современные методы диагностики, лечения и ее влияние на здоровье плода и ребенка. Инновационные исследования в современном мире: теория и практика. 2024; 3(8): 25-28. DOI: https://doi.org/10.5281/zenodo.12703983</mixed-citation><mixed-citation xml:lang="en">Soleeva N, Gulshaido M, Nasimova N. Placental insufficiency: modern methods of diagnosis, treatment and its impact on the health of the fetus and child. Innovative research in the modern world: theory and practice. 2024; 3(8): 25-28. (In Russ.). DOI: https://doi.org/10.5281/zenodo.12703983</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шадеева Ю.А., Гурьева М.Г., Николаева Н.В., Евтушенко Ю.А., Шадеева, В.А. Прогнозирование риска внутриутробной инфекции плода при сверхранних и ранних преждевременных родах, индуцированных разрывом околоплодных оболочек. Акушерство, Гинекология и Репродукция. 2020;14(4):490-501. DOI: https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.110</mixed-citation><mixed-citation xml:lang="en">Shadaeva YA, Guryeva MG, Nikolaeva NV, Yevtushenko YA, Shadeeva VA. Prediction of the risk of intrauterine fetal infection in very early and early preterm birth induced by rupture of membranes. Obstetrics Gynecology and Reproduction. 2020;14(4):490-501. (In Russ.). DOI: https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.110</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Марочко Т.Ю., Леванова Л.А., Колесникова Н.Б., Сурина М.Н., Карелина О.Б., Копытова К.Р. Клинические и морфологические параллели при микробной колонизации плаценты. Фундаментальная и клиническая медицина. 2019;2(4):32-37. DOI: https://doi.org/10.23946/2500-0764-2019-4-4-32-37</mixed-citation><mixed-citation xml:lang="en">Marochko TY, Levanova LA, Kolesnicova NB, Surina MN, Karelina OB, Kopytova KR. Clinical and morphological parallels in microbial colonization of the placenta. Fundamental and clinical medicine. 2019;2(4):32-37. (In Russ.). DOI: https://doi.org/10.23946/2500-0764-2019-4-4-32-37</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Белокриницкая Т.Е., Витковский Ю.А., Фролова Н.И. Роль цитокинов и интерферонов при беременности. Фундаментальная и клиническая медицина. 2024;9(3):98-108. DOI: https://doi.org/10.23946/2500-0764-2024-9-3-98-108</mixed-citation><mixed-citation xml:lang="en">Belokrinitskaya TE, Vitkovsky YA, Frolova NI. The role of cytokines and interferons during pregnancy. Fundamental and clinical medicine. 2024;9(3):98-108. (In Russ.). DOI: https://doi.org/10.23946/2500-0764-2024-9-3-98-108</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Vilotić A, Nacka-Aleksić M, Pirković A, Bojić-Trbojević Ž, Dekanski D, Jovanović Krivokuća M. IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies. Int J Mol Sci. 2022 Nov 23;23(23):14574. DOI: https://doi.org/10.3390/ijms232314574</mixed-citation><mixed-citation xml:lang="en">Vilotić A, Nacka-Aleksić M, Pirković A, Bojić-Trbojević Ž, Dekanski D, Jovanović Krivokuća M. IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies. Int J Mol Sci. 2022 Nov 23;23(23):14574. DOI: https://doi.org/10.3390/ijms232314574</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
